1. Home
  2. SAVA vs LNN Comparison

SAVA vs LNN Comparison

Compare SAVA & LNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAVA
  • LNN
  • Stock Information
  • Founded
  • SAVA 1998
  • LNN 1954
  • Country
  • SAVA United States
  • LNN United States
  • Employees
  • SAVA N/A
  • LNN N/A
  • Industry
  • SAVA Biotechnology: Pharmaceutical Preparations
  • LNN Industrial Machinery/Components
  • Sector
  • SAVA Health Care
  • LNN Industrials
  • Exchange
  • SAVA Nasdaq
  • LNN Nasdaq
  • Market Cap
  • SAVA 1.3B
  • LNN 1.4B
  • IPO Year
  • SAVA N/A
  • LNN 1988
  • Fundamental
  • Price
  • SAVA $27.08
  • LNN $123.11
  • Analyst Decision
  • SAVA Buy
  • LNN Strong Buy
  • Analyst Count
  • SAVA 3
  • LNN 3
  • Target Price
  • SAVA $107.00
  • LNN $138.00
  • AVG Volume (30 Days)
  • SAVA 1.9M
  • LNN 62.5K
  • Earning Date
  • SAVA 11-05-2024
  • LNN 10-17-2024
  • Dividend Yield
  • SAVA N/A
  • LNN 1.17%
  • EPS Growth
  • SAVA N/A
  • LNN 2.34
  • EPS
  • SAVA N/A
  • LNN 6.58
  • Revenue
  • SAVA N/A
  • LNN $619,207,000.00
  • Revenue This Year
  • SAVA N/A
  • LNN N/A
  • Revenue Next Year
  • SAVA N/A
  • LNN $13.62
  • P/E Ratio
  • SAVA N/A
  • LNN $18.68
  • Revenue Growth
  • SAVA N/A
  • LNN N/A
  • 52 Week Low
  • SAVA $8.79
  • LNN $106.46
  • 52 Week High
  • SAVA $42.20
  • LNN $137.31
  • Technical
  • Relative Strength Index (RSI)
  • SAVA 46.80
  • LNN 53.41
  • Support Level
  • SAVA $26.10
  • LNN $121.76
  • Resistance Level
  • SAVA $31.65
  • LNN $124.99
  • Average True Range (ATR)
  • SAVA 2.55
  • LNN 2.13
  • MACD
  • SAVA -0.50
  • LNN -0.05
  • Stochastic Oscillator
  • SAVA 15.08
  • LNN 24.21

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.

About LNN Lindsay Corporation

Lindsay Corp provides various proprietary water management and road infrastructure products and services. It has operations categorized into two main reporting segments: Irrigation, and Infrastructure. The company generates maximum revenue from the Irrigation segment. Its Irrigation segment includes manufacturing and marketing center pivot, lateral move, and hose reel irrigation systems, as well as various technology solutions such as GPS positioning and guidance, variable rate irrigation, wireless irrigation management, M2M communication technology, and smartphone applications. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: